The FDA's final guidance on SIUU establishes a safe harbor for some manufacturer communications to healthcare providers about off-label uses. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
